T-DM1 impresses at ASCO

被引：0
|
作者：
Malini Guha
机构：
来源：
Nature Biotechnology | 2012年 / 30卷 / 8期
关键词：
D O I：
10.1038/nbt0812-728
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：728 / 728
相关论文
共 50 条
  • [21] TREATMENT OF ADVANCED BREAST CANCER WITH T-DM1 IN A CANCER CENTER
    Pereira, Filipa Ferreira
    Magalhaes, Helena
    Alves, Sara
    Vieira, Claudia
    Pimentel, Isabel
    Oliveira, Cristina
    Abreu, Miguel
    Bordalo e Sa, Joana
    Rodrigues, Ana
    Ferreira, Ana
    Oliveira, Julio
    Ferreira, Marta
    Pousa, Ines
    Couto, Rosario
    Sousa, Susana
    Pereira, Deolinda
    BREAST, 2017, 36 : S55 - S56
  • [22] Thrombokinetic studies of ado-trastuzumab emtansine (T-DM1)
    Gadi, V. K.
    Butler, B. S.
    Corson, J.
    Slichter, S. J.
    CANCER RESEARCH, 2016, 76
  • [23] An UPLC Method for Determination of Structural Analogues of DM1: the Payload of Trastuzumab Emtansine (T-DM1)
    Yao, Junliang
    Zhu, Yang
    Yin, Daquan
    CHROMATOGRAPHIA, 2025, 88 (01) : 11 - 18
  • [24] Synthesis of 64Cu-DOTA-T-DM1 and preliminary evaluation as a potential companion diagnostic agent for T-DM1
    Kim, H.
    Lee, I.
    Shin, E.
    Lee, E.
    Yoo, R.
    Chung, H.
    Shim, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S675 - S675
  • [25] Effect of trastuzumab emtansine (T-DM1) on autologous platelet kinetics.
    Gadi, Vijyakrishna
    Corson, Jill
    Cundy, Arianne
    Bailey, Shawn
    Pellham, Esther
    Christoffel, Todd
    Gettinger, Irena
    Barroso, Jeffrey
    Slichter, Sherrill
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [26] T-DM1 Reduces HER2+Breast Cancer Recurrence
    Harper, Kristin
    CANCER DISCOVERY, 2019, 9 (02) : 158 - 159
  • [27] Multiple spider telangiectasias in a breast cancer patient on T-DM1 treatment
    Ruiz-Rivero, Juncal
    Horcajada-Reales, Celia
    Tardio, Juan C.
    Manuel Borbujo-Martinez, Jesus
    ANAIS BRASILEIROS DE DERMATOLOGIA, 2018, 93 (06) : 938 - 939
  • [28] Cardiotoxicity of trastuzumab emtansine (T-DM1): a single-center experience
    Acibuca, Aynur
    Sezer, Ahmet
    Yilmaz, Mustafa
    Sumbul, Ahmet Taner
    Demircan, Senol
    Muderrisoglu, Ibrahim Haldun
    Ozyilkan, Ozgur
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2021, 49 (12)
  • [29] Adjuvant pertuzumab plus trastuzumab or adjuvant T-DM1; Which is better?
    Altundag, Kadri
    JOURNAL OF BUON, 2021, 26 (03): : 1170 - 1170
  • [30] Central neurotoxicity induced by trastuzumab emtansine (T-DM1): a case report
    Papageorgiou, Georgios I.
    Symeonidis, David G.
    Tsakatikas, Sergios A.
    Liatsos, Alexandros D.
    Douglas, Konstantinos A. A.
    Douglas, Vivian P.
    Moschos, Marilita M.
    Kosmas, Christos
    ANTI-CANCER DRUGS, 2021, 32 (10) : 1146 - 1149
12345